These international patent data are derived from patent families, based on US drug-patent linkages.
Accordingly, they should not be regarded as comprehensive records of ex-US drug-patent associations.
|US Patent Number||US Expiration Date||US Applicant||US Tradename||Generic Name|
|8,168,616||Jul 3, 2026|
aliskiren hemifumarate; valsartan
|8,618,174||Nov 15, 2021|
aliskiren hemifumarate; amlodipine besylate; hydrochlorothiazide
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
Export unavailable in trial.
Subscribe for complete access.